Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EUCRU
Eucrates Biomedical Acquisition
$10.02
+0.1%
$10.02
$9.76
$10.66
N/AN/A1,921 shs21,500 shs
GTAX
(GTAX)
$0.00
$0.00
$0.00
N/AN/AN/AN/A
JFKKU
8i Enterprises Acquisition
$10.80
-7.2%
$10.80
$9.72
$26.99
N/AN/A3,516 shs900 shs
PAIR
(PAIR)
$0.00
$0.00
$0.00
N/AN/AN/AN/A
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EUCRU
Eucrates Biomedical Acquisition
0.00%0.00%0.00%0.00%0.00%
JFKKU
8i Enterprises Acquisition
0.00%0.00%0.00%0.00%0.00%
PAIR
(PAIR)
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
EUCRU
Eucrates Biomedical Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
GTAX
(GTAX)
N/AN/AN/AN/AN/AN/AN/AN/A
JFKKU
8i Enterprises Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
PAIR
(PAIR)
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EUCRU
Eucrates Biomedical Acquisition
0.00
N/AN/AN/A
GTAX
(GTAX)
0.00
N/AN/AN/A
JFKKU
8i Enterprises Acquisition
0.00
N/AN/AN/A
PAIR
(PAIR)
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EUCRU
Eucrates Biomedical Acquisition
N/AN/AN/AN/AN/AN/A
GTAX
(GTAX)
N/AN/AN/AN/AN/AN/A
JFKKU
8i Enterprises Acquisition
N/AN/AN/AN/AN/AN/A
PAIR
(PAIR)
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EUCRU
Eucrates Biomedical Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
GTAX
(GTAX)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
JFKKU
8i Enterprises Acquisition
N/AN/A0.00N/AN/AN/AN/AN/A
PAIR
(PAIR)
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EUCRU
Eucrates Biomedical Acquisition
N/AN/AN/AN/AN/A
GTAX
(GTAX)
N/AN/AN/AN/AN/A
JFKKU
8i Enterprises Acquisition
N/AN/AN/AN/AN/A
PAIR
(PAIR)
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
EUCRU
Eucrates Biomedical Acquisition
N/A
GTAX
(GTAX)
N/A
JFKKU
8i Enterprises Acquisition
N/A
PAIR
(PAIR)
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
EUCRU
Eucrates Biomedical Acquisition
4N/AN/ANot Optionable
GTAX
(GTAX)
N/AN/AN/ANot Optionable
JFKKU
8i Enterprises Acquisition
N/AN/AN/ANot Optionable
PAIR
(PAIR)
N/AN/AN/ANot Optionable

Recent News About These Companies

No headlines for this company have been tracked by MarketBeat.com

Eucrates Biomedical Acquisition OTCMKTS:EUCRU

$10.02 +0.01 (+0.10%)
As of 04/26/2023

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

(GTAX) OTCMKTS:GTAX

Gilman Ciocia, Inc. provides federal, state and local taxes preparation services to individuals, predominantly in the middle and upper income tax brackets, accounting services to small and midsize companies and financial planning services, including securities brokerage, investment management services, insurance and financing services. As of June 30, 2012, the Company had 27 offices operating in three states (New York, New Jersey, and Florida). The Company also provides financial planning services through approximately 33 independently owned and operated offices in 10 states. The Company's financial planning clients are introduced to the Company through the Company's tax return preparation services, accounting services and educational workshops. In October 2013, National Holdings Corporation announced that it has the completed the merger with Gilman Ciocia, Inc.

8i Enterprises Acquisition OTCMKTS:JFKKU

$10.80 -0.84 (-7.22%)
As of 09/30/2020

8i Enterprises Acquisition Corp. intends to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination. The company was founded in 2017 and is based in Singapore.